Eficacia y seguridad de biopsia de próstatafusión con software transperineal

Purpuse: To evaluate the efficacy and safety of software-guided transperineal prostate biopsy fusion in detecting prostatecancer compared to conventional techniques. Methods: Descriptive, observational, and retrospective study in 100 patientsover 40 years old with PIRADS ≥ 3 and PSA < 20, undergoing transperineal prostate biopsy fusion at Clínica Internacional fromNovember 2022 to June 2023. Diagnostic accuracy and cancer detection rates were analyzed. Results: The average age was67.6 years. The cancer detection rate was 71%, and 49% for clinically significant prostate cancer (CSPC). Complications wereminimal (2%). The fusion technique significantly improved diagnostic accuracy compared to conventional transrectal biopsies. Discussion: Software-guided transperineal biopsy fusion showed high efficacy in detecting CSPC, superior to conventional techniques, with a low complication rate. The precision in identifying suspicious areas through image fusion improves cancer detection. Conclusions: Software-guided transperineal prostate biopsy fusion is a safe and effective technique for prostate cancer detection, improving diagnostic accuracy and reducing complications compared to conventional techniques.